Member Info for Scinv_temp

Nope. Wasn't me. But you know what I hope you are right and it means something, I still have shares it woud great to conclude this adventure

I don't think you understand what EUA actually is.

Doc. There is no EUA without quantities of the drug available. SNG said the plan is to go for a full approval in the summer. That's the plan anyway. The EUA is speculation coming from investors and I am suggesting that without a pile, even half or a third of the total monthly output RM suggested would do for initial supply. But do they have it?

There is home but then there is outparient (thry do tests anyway in that setting) then there is hospital and then icu within hospital.

Doc do you have any idea how simple it is to have an anti-ifn antibody self-test? Of course someone should have been developing it. Easy/simple in this context means knowing exactly what needs to be done and going ahead and doing it, not you and I renting a garage space and making one there type of simple. But it would be straightforward as far as antibody tests go. The reason they ask for frozen plasma in the activ 2 is because, probably the are going to check all the samples in one go at some point instead of one by one, but if somebody bothered to make it, it would be a 5-10 min type of quick self test that could easily be taken before treatment. Anyway, even in an outpatient setting, it would not take more than 30 min as it is now.

About the rest, there is selling and buying in the stock market and it is not even as binary as that. Then there is risk adjustment, each to their own but if one decides to hold the whole of their position that is their decision, it doesn't make them "heroes" or "good". This is ridiculous though I understand the stock market isn't your thing so you get your examples from this lot here. Whoever gave you the idea that someone should not talk about reducing their position but only talk about increasing it simply gave you a VERY bad example of how talking about stocks in any serious or even non-ridiculous casual way works. My opinion.

I said ramping buddies

*know

I don't who is the admin, do you?

Deramping??

Where is it?

Post the comments that show this excessive repetition though. Yeah?
Then take a look your post history and at some other like minded accounts here, see if you can find any patterns there as well

You delete every constructive critisism and fill the board with dreamland conjectures. Surely you are not selling while you are pumping, right?

What broken record? Whay are you referring to?
Can post a link to the comments you are referring to?

Thanks ;)

Since you once again deleted a thread that has critisism, just like you did before, I posted my comment on that thread on my reddit account

Agreed Tommo

Short answer is yes in part, the principle of the treatment is established by the overall literature and increases confidence in the results, but the results need to be there as the primciple refers to the mechanism of action of the active ingredient while approval is for a specific drug/indication/protocol.

For example, if there are studies that suggest that ifns are effective in patients with autoantibodies, one still needs to.show that with their drug it does in fact benefit those patients with ifn deficiencies. Or, after RMs recent comments, if literature suggests that ifnb can enhance antibody production im infected patients, one needs to show that with their drug actually does have that benefit in patients. If literature says that variants are even better that blocking ifn response but can still be tackled with ifns, one has to show that at least with some in vitro or even better animal studies.

Far and above all, there are 142 trials on clinicaltrials website that mentions interferons for covid19. Some of them (from china) include inhaled or "atomized" ifn alpha since beginning of February 2020 or March etc, in any case early. Beta seems the better option, but there are studies for that as well.

Also keep in mind that "E" in EUA means "emergency", which means for that they need to have meaningful quantities available NOW, perhaps doesn't have to be 100K treatments right now, but it does have to be something meaningful otherwise there is no point for an EUA and remember RM actually did say they are not going for EUA and they hope to apply for full approval in the summer. Assuming they have the data they need.

"You know your shares are safe and excellent news is about to drop

It really is pretty easy to spot"

Only a few minutes ago this guy and his friends were cautioning aginst conjectures.

Dude, you need to understand that YOU and the gang are the ones disrupting and creating a bad climate

The thing is activ has multiple drugs and adding new ones while the status refers to the whole trial platform. So I guess it will switch to "not recruiting" when they decide to wrap the whole project but not for individual drugs.

Yes, isn't obvious from what } wrote that we don't know? I did clearly say it could this or it could be that, isn't that self explanatory?

What I did try to do is to discuss how the placebos work in the activ 2 trial, using the information that they published.

That's what the activ people say, not me. So that is what we know.
Thanks for filtering, hopefully now I won't see you reply to my posts since you can't see them.

These are described on pages 62 and 63 of the master protocol. The figure earlier in the document is meant to outline the concept, not to describe all possible scenario. For example, apart from low risk/high risk there are other criteria such us time since symptom onset etc. So it could be that it is 1:1 or it could be that it shares placebo with another non infused agent etc